Conclusions: Tigecycline demonstrated excellent activity against all the commonly isolated pathogens from Indonesia, including those being multidrug-resistant to other antimicrobial classes. Tigecycline shows promise for therapy of indicated, antimicrobial-resistant species in this nation and indeed, the entire Asia-Pacific region.
InTroDuCTIon
Tigecycline, a novel glycylcycline, represents an important advance in the treatment for a range of infections where mixed and/or resistant organisms occur. It is able to bypass the standard mechanisms of tetracycline resistance, and hence has a very broad spectrum that includes virtually all Gram-positive bacteria, most Gram-negative bacteria including anaerobes, and many strains harbouring resistance to other antimicrobials. Information on the prevalence of resistance in pathogens isolated in Indonesia has been limited, although there has been a suspicion that resistance rates could be elevated. The study provided an opportunity to examine the prevalence of resistance in key human pathogens isolated from clinical sources in Indonesia, and to examine the in vitro activity of tigecycline against those pathogens.
MATerIAlS AnD MeTHoDS
Bacterial isolates: Non-duplicate clinically significant patient isolates were submitted from four medical centres from Indonesia. Species identification of all isolates was confirmed in a central laboratory (Women's and Children's Hospital, Adelaide, Australia) using reference methodologies.
Susceptibility tests: Isolates were tested against tigecycline using validated broth microdilution MIC panels with cationadjusted Mueller-Hinton broth (TREK Diagnostic Systems; East Grinstead, UK 
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reSulTS
• A total of 572 (493 Gram-negative and 79 Gram-positive) isolates were processed. The rank order of pathogens is shown in Table 1 .
• The prevalence of screen-positive ESBL strains was high among E. coli (37%) and K. pneumoniae (43%).
• Tigecycline MIC distributions and MIC 50 / MIC 90 against the most common species are found in Table 2 . Apart from the Proteae, 100% of Enterobacteriaceae, including screen-positive ESBL E. coli and K. pneumoniae strains, had tigecycline MIC values at ≤2 mg/L ( Table 2) .
ConCluSIonS
• Tigecycline demonstrated excellent activity against all commonly isolated pathogens from Indonesia, including those multidrug-resistant to other antimicrobial classes. • The presence of tetracycline resistance determinants resulted in minimal elevations of tigecycline MIC values, but were most noticeable in K. pneumoniae and oxacillinresistant S. aureus (Figure 1 ).
• The potency and susceptibility of tigecycline and comparator agents tested against the most common pathogens collected from Indonesian patients are shown in Table 3 .
• Tigecycline shows promise for therapy of indicated, antimicrobial-resistant species in this nation and indeed, across the entire Asia-Pacific region
